ArticleActa neurologica Belgica2025
Atypical presentation of spinal schistosomiasis with involvement of the cervicothoracic spine.
Article in Acta neurologica Belgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 25-year-old patient, born in Eritrea who had lived for 7 years in Nigeria before he arrived in France 1 year ago, was referred for subacute and progressive tetraparesis evolving over 2 months. Examination revealed tetraparesis, impairment of sensory function below the C6 level and tetrapyramidal syndrome. Spine MRI showed increased T2 intensity at the C6 to T11 spinal cord levels consistent with a longitudinally extensive transverse myelitis. After gadolinium administration, a diffuse, nodular, and heterogeneous pattern of contrast enhancement was seen. Cerebrospinal fluid disclosed pleocytosis with 14% eosinophils, associated with an elevated protein level. Exhaustive analysis ruled out bacterial, viral, mycobacterial, or fungal infection. The diagnosis of spinal schistosomiasis was confirmed by detection of S. mansoni DNA in blood and cerebrospinal fluid by polymerase chain reaction (PCR). Treatment with praziquantel was initiated. The clinical course was favourable and follow-up spine MRI at 6 months disclosed a dramatic reduction in the T2 signal abnormality without contrast enhancement. Our case is notable because of the cervicothoracic involvement and because a post-therapeutic MRI was available, confirming the patient's favourable evolution.
Indexed as
Identifiers
41065993What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.